| A Systematic Review and Meta-Analysis of HCV Clearance | Liver international |  | | 2017 | 615 | 1 |
|
| Weighted Genetic Risk Scores and Prediction of Weight Gain in Solid Organ Transplant Populations | PloS one |  | | 2016 | 540 | 275 |
|
| Polymorphisms in the lectin pathway of complement activation influence the incidence of acute rejection and graft outcome after kidney transplantation | Kidney international | | | 2016 | 508 | 663 |
|
| PTX3 Polymorphisms and Invasive Mold Infections After Solid Organ Transplant | Clinical infectious diseases | | | 2015 | 545 | 1 |
|
| Corrigendum: reduced IFNλ4 activity is associated with improved HCV clearance and reduced expression of interferon-stimulated genes | Nature communications | | | 2015 | 592 | 183 |
|
| Influence of IFNL3/4 Polymorphisms on the Incidence of Cytomegalovirus Infection After Solid-Organ Transplantation | The Journal of infectious diseases | | | 2015 | 739 | 0 |
|
| IL1B and DEFB1 Polymorphisms Increase Susceptibility to Invasive Mold Infection After Solid-Organ Transplantation | The Journal of infectious diseases | | | 2015 | 692 | 2 |
|
| The novel ss469415590 variant predicts virological response to therapy in patients with chronic hepatitis C virus type 1 infection | Alimentary pharmacology & therapeutics | | | 2014 | 651 | 0 |
|
| The IFNL3/4 ΔG variant increases susceptibility to cytomegalovirus retinitis among HIV-infected patients | AIDS | | | 2014 | 581 | 0 |
|
| Reduced IFNλ4 activity is associated with improved HCV clearance and reduced expression of interferon-stimulated genes | Nature communications | | | 2014 | 689 | 1,270 |
|
| Genetic analyses reveal a role for vitamin D insufficiency in HCV-associated hepatocellular carcinoma development | PloS one | | | 2013 | 719 | 670 |
|
| Comparative genetic analyses point to HCP5 as susceptibility locus for HCV-associated hepatocellular carcinoma | Journal of hepatology | | | 2013 | 682 | 0 |
|
| IL28B expression depends on a novel TT/-G polymorphism which improves HCV clearance prediction | The Journal of experimental medicine | | | 2013 | 585 | 0 |
|
| IL28B polymorphisms predict response to therapy among chronic hepatitis C patients with HCV genotype 4 | Journal of viral hepatitis | | | 2013 | 654 | 0 |
|
| IL28B polymorphisms do not predict response to therapy in chronic hepatitis C with HCV genotype 5 | Gut | | | 2012 | 603 | 0 |
|
| Serum ferritin levels are associated with a distinct phenotype of chronic hepatitis C poorly responding to pegylated interferon-alpha and ribavirin therapy | Hepatology | | | 2012 | 655 | 0 |
|
| A genetic validation study reveals a role of vitamin D metabolism in the response to interferon-alfa-based therapy of chronic hepatitis C | PloS one | | | 2012 | 781 | 442 |
|
| IL28B alleles associated with poor hepatitis C virus (HCV) clearance protect against inflammation and fibrosis in patients infected with non-1 HCV genotypes | Hepatology | | | 2012 | 674 | 0 |
|
| Genome-wide association study identifies variants associated with progression of liver fibrosis from HCV infection | Gastroenterology | | | 2012 | 641 | 0 |
|
| The impact of fibrosis and steatosis on early viral kinetics in HCV genotype 1-infected patients treated with Peg-IFN-alfa-2a and ribavirin | Journal of viral hepatitis | | | 2012 | 642 | 0 |
|
| IL28B polymorphisms predict reduction of HCV RNA from the first day of therapy in chronic hepatitis C | Journal of hepatology | | | 2011 | 622 | 0 |
|
| Response prediction in chronic hepatitis C by assessment of IP-10 and IL28B-related single nucleotide polymorphisms | PloS one | | | 2011 | 647 | 343 |
|
